Does HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN Cause Off label use? 83 Reports in FDA Database

Q: Does HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN cause Off label use?

83 reports of Off label use have been filed with the FDA for HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN, representing 1.9% of all HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN adverse event reports.

Q: How dangerous is Off label use from HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN?

Of 83 reports, 19 (22.9%) resulted in death and 42 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 83 reports of Off label use have been filed in association with HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN. This represents 1.9% of all adverse event reports for HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN.

Reports of Off label use with HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN

1.9%

of all HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN reports

Deaths

Hospitalizations

How Dangerous Is Off label use From HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN?

Of the 83 reports, 19 (22.9%) resulted in death, 42 (50.6%) required hospitalization.

Is Off label use Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN. However, 83 reports have been filed with the FAERS database.

What Other Side Effects Does HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN Cause?

Sinusitis (436) Headache (375) Fatigue (336) Malaise (259) Pneumonia (259) Pyrexia (249) Death (231) Infusion site pain (230) Nausea (223) Covid-19 (215)

What Other Drugs Cause Off label use?

RITUXIMAB (39,751) INFLIXIMAB (34,801) DENOSUMAB (34,612) METHOTREXATE (24,020) VEDOLIZUMAB (21,017) ETANERCEPT (20,178) TOCILIZUMAB (18,256) PREDNISONE (17,867) LENALIDOMIDE (17,017) ADALIMUMAB (16,417)

Which HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN Alternatives Have Lower Off label use Risk?

HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN vs HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE, RECOMBINANT HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN vs HUMAN RABIES VIRUS IMMUNE GLOBULIN HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN vs HUMAN RHO IMMUNE GLOBULIN HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN vs HUMIRA HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN vs HUMIRA PEN

HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN Full Profile All Off label use Reports All Drugs Causing Off label use HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN Demographics